Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-09-12
1985-11-19
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514375, 548165, 548221, C07D27768, C07D26358, A61K 3142, A61K 13425
Patent
active
045542848
ABSTRACT:
Certain aminoethyl substituted 1,3-benzthiazol- and 1,3-benzoxazol-2(3H)-ones are D.sub.2 -dopamine agonists. These compounds are prepared by reacting an appropriate o-aminophenol or thiophenol with phosgene.
REFERENCES:
patent: 4314944 (1982-02-01), Huffman et al.
patent: 4452808 (1984-06-01), Gallagher, Jr.
patent: 4460581 (1984-07-01), Schromm
patent: 4474965 (1984-10-01), D'Amico
Stringer Orum D.
Weinstock Joseph
Edgerton William H.
Foggio Richard D.
Gerstl Robert
Lourie Alan D.
SmithKline Beckman Corporation
LandOfFree
7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-84090